Glenmark Pharmaceuticals Inc., USA recalls
Glenmark Pharmaceuticals Inc., USA is named on 36 recalls in Recall Relay's records since November 2023, from FDA (106 recalled products: FDA lists each product as its own recall); the most recent was October 9, 2026.
All 106 recalled products, newest first.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Abiraterone Acetate Tablets USP 500 mgLabeling: Not Elsewhere Classified
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid GelCGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Alyacen 7/7/7Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally Disintegrating TabletsDefective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
-
Class IIIofficial
Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide TabletsCross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
-
Class IIIofficial
Glenmark Pharmaceuticals Inc., USA recalls Nebivolol TabletsCross Contamination with Other Products
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid GelCGMP Deviations: Market complaints received for gritty texture (grainy)
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls VioreleFailed Impurities/Degradation Specifications
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Theophylline extended-release tablets 400mgFailed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval, wherein the dissolution results do not comply with L3 stage dissolution criteria.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
-
Class IIIofficial
Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin TabletsFailed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Theophylline (Anhydrous) Extended-Release TabletsOOS results reported for the Dissolution (by UV) test.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Fluphenazine Hydrochloride Tablets 2.5mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Teriflunomide TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Solifenacin Succinate Tablets 10MGCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Voriconazole Tablets 200 mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Propafenone Hydrochloride Extended-Release Capsules 225mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Lacosamide TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Nitroglycerin Sublingual Tablets 0.3MGCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Clindamycin Hydrochloride CapsulesCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Indomethacin Extended-Release CapsulesCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Rosuvastatin Tablets 40mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Propafenone Hydrochloride Extended-Release CapsulesCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Fluphenazine Hydrochloride TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Lacosamide Tablets 200mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Pravastatin Sodium Tablets 80mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Rufinamide Tablets 200mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Propafenone Hydrochloride Extended-Release Capsules USPCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Pravastatin Sodium TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Lacosamide TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Acetaminophen and Ibuprofen (NSAID) TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Nitroglycerin Sublingual Tablets 0.4MG 100-count cartonCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Saxagliptin Tablets 5mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Colesvelam Hydrocholoride Tablets 625mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Voriconazole Tablets 50mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Propafenone Hydrochloride Extended-Release Capsules 325mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Lacosamide Tablets 150mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Saxagliptin TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Prochlorperazine Maleate TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Gabapentin Tablets 600mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Solifenacin Succinate Tablets 5mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Metformin Hydrochloride Extended-Release Tablets 1000mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Pravastatin Sodium TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Naproxen Sodium TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Frovatriptan Succinate Tablets 2.5mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Fenofibrate Capsules 67 mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Pravastatin Sodium TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 1000mgCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Cetirizine Hydrochloride TabletsCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsCGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 6.25 mgCGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 3.125mg Tablets a.)100-count bottle (NDC 68462-162-01)CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 12.5 mgCGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 25 mgCGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsCGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsCGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release CapsulescGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release CapsulescGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release CapsulescGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release CapsulescGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release CapsulescGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release CapsulescGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
-
Class IIIofficial
Glenmark Pharmaceuticals Inc., USA recalls Ciclopirox Gel 0.77%Defective Container: Firm received complaints of broken tube at the seal.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal SprayDefective Delivery System: The dip tube is clogged causing the spray not to work.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Mupirocin OintmentSubpotent Drug
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Indomethacin Extended-Release CapsulesFailed Dissolution Specifications: below specification results
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls GlenmarkCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Pravastatin Sodium TabletsFailed Dissolution Specifications: results below specifications
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Potassium Chloride Extended-Release CapsulesCGMP Deviations
-
Class Iofficial
Glenmark Pharmaceuticals Inc., USA recalls Potassium Chloride Extended-Release CapsulesFailed Dissolution Specifications
-
Class Iofficial
Glenmark Pharmaceuticals Inc., USA recalls Potassium Chloride Extended-Release CapsulesFailed Dissolution Specifications
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Potassium Chloride Extended-Release CapsulesCGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Rizatriptan Benzoate Orally Disintegrating TabletsCGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Rizatriptan Benzoate Orally Disintegrating TabletsCGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Rizatriptan Benzoate Tablets USPCGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Rizatriptan Benzoate Tablets USPCGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Fluocinolone Acetonide OilFailed Excipient Specifications: OOS for assay of Isopropyl Alcohol
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Indomethacin 25mg CapsulesLabeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Naproxen TabletsLabeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mgFailed Dissolution Specifications: Out of specification for dissolution.
-
Class IIIofficial
Glenmark Pharmaceuticals Inc., USA recalls Esomeprazole Magnesium Delayed-Release CapsulesFailed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH).
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Deferasirox Tablets for Oral SuspensionFailed Dissolution Specifications
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Glenmark Pharmaceuticals Inc., USA or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts